Joshua Richter, MD, Assistant Professor, Division of Hematology and Medical Oncology @TischCancer considers the Phase 3 ICARIA-MM study investigating isatuximab in relapsed/refractory multiple myeloma patients.
Phase 3 ICARIA-MM Study @TischCancer
Joshua Richter, MD, Assistant Professor, Division of Hematology and Medical Oncology @TischCancer considers the Phase 3 ICARIA-MM study investigating isatuximab in relapsed/refractory multiple myeloma patients.